Clinical Trial Update: Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for vinflunine in relapsed extensive small cell lung cancer have been completed and posted. The results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Vinflunine (vinflunine)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Carcinoma, Small Cell, Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-13